Sinopharm Kicks Off National Emergency Allocation System For Medical Reserves
This article was originally published in PharmAsia News
On the instruction of the National Development and Reform Commission, China National Pharmaceutical Group Corporation (Sinopharm) has shipped the first batch of ventilators, ECG monitors, surgical instruments and transfusion equipment to earthquake-hit regions in Sichuan. Responsible for national medical reserves, Sinopharm has set up an emergency allocation system and a group leading rescue efforts. All subsidiaries involved in the exercise are tasked to ensure the specifications and quantity of medical reserves correspond to NDRC's predetermined catalog, as well as make emergency procurement of necessary medicines and devices outside the catalog. Logistics centers in Beijing, Shanghai and Tianjin and major warehouses have been notified to stand by for medical allocation assignments at a moment's notice. (Click here for more - Chinese Language)
You may also be interested in...
With the global pandemic leading to a big rise in mental health issues, medtech could have a role to play. The first of a two-part series on mental health focuses on transcranial magnetic stimulation systems. See what Neuronetics’ CEO Stephen Furlong said about it here.
US FDA declines to review the CCR5 antagonist for use in highly treatment-experienced HIV patients. Safety data from an ongoing study should be sufficient to address the agency’s concerns about the higher 700mg dose, CytoDyn management says, but FDA also has questions about the production of the self-injectable syringes.
Mallinckrodt's drug to treat hepatorenal syndrome met its primary endpoint of HRS reversal but FDA wants reassurance that this surrogate endpoint translates into a treatment effect on clinical outcomes. A greater incidence of respiratory failure in those receiving terlipressin "remains a significant safety concern," the agency says.